Viewing Study NCT03754803


Ignite Creation Date: 2025-12-24 @ 7:17 PM
Ignite Modification Date: 2026-02-27 @ 3:13 AM
Study NCT ID: NCT03754803
Status: COMPLETED
Last Update Posted: 2025-08-17
First Post: 2018-10-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany
Sponsor: ViiV Healthcare
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dolutegravir View
None Two-drug regimen View
None Human Immunodeficiency Virus View
None HIV Symptom Distress Module View
None Lamivudine View
None HIV treatment satisfaction questionnaire View